Mass-treatment and insecticide-spraying of animal reservoirs for emergency control of Rhodesiense sleeping sickness in Uganda.
Recent reports indicate that the area affected by T.b. rhodesiense sleeping sickness has increased 2.5-fold since 1985 (4), extending further north into Soroti, Kaberamaido, Apac, Lira districts (6) and probably Gulu district. This northern spread of the disease could easily lead to the merger of the south-eastern T.b. rhodesiense sleeping sickness focus with the north-western T.b. gambiense focus. This is likely to complicate the epidemiology and control of the two forms of the disease. According to Simarro et al (7), T.b. rhodesiense cases reported in Uganda from 2000 to 2009 were: 300 (2000), 426 (2001), 329 (2002), 338 (2003), 335 (2004), 473 (2005), 261 (2006), 119 (2007), 138 (2008) and 129 (2009)7. Most of these cases were reported in Iganga, Soroti, Kaberamaido, Dokolo and Lira7. Most cases of T.b. rhodesiense are linked to livestock reservoirs7. Livestock reservoirs are important especially in south-east Uganda where these are responsible for over 50% of the reported cases of T.b. rhodesiense cases during the period 2000 to 2009 (7).
Control of sleeping sickness mainly relies on case finding and treatment (8) coupled with tsetse control during epidemics to suppress transmission. Case finding is normally focused on screening people in and around known foci of the disease. Though not widely practised, there is growing evidence that domestic animal reservoirs, including cattle, pigs and small ruminants need to be treated to prevent persistence and spread of T.b. rhodesiense sleeping sickness (9-11). The zoonotic nature of T.b. rhodesiense is well recognized, and cattle and pigs have long been reported to be its major reservoirs in south-east Uganda (10, 12-15). Animal reservoirs have been incriminated in the persistence of T.b. rhodesiense sleeping sickness in old foci (10). Movement of cattle from sleeping sickness endemic areas during restocking programs is responsible for emergence of new foci (9). It is reported that up to 18% of the domestic animals in emerging sleeping sickness foci may be acting as reservoirs for the disease (5).
Whereas the role of animal reservoirs is well-documented in the epidemiology of T.b. rhodesiense sleeping sickness, targeting of animal reservoirs is rarely exploited in the control of sleeping sickness. Moreover, case studies on this control intervention in Rhodesiense sleeping sickness foci in Africa and their follow-up reports are scarce. Hence, we present a case study and its follow-up report on three sleeping sickness foci in south-east Uganda where mass-treatment and insecticide-spraying of cattle and pigs were applied to suppress outbreaks of T.b. rhodesiense sleeping sickness and monitored over a period of up to 17 years.
Buteba, Kisoko and Osukuru sleeping sickness foci are located in Tororo district in south-east Uganda, an area predominantly infested with G. fuscipes fuscipes. Sleeping sickness outbreaks are normally focalized; affecting a cluster of tsetse-infested villages (16). Communities in these villages practise mixed crop-livestock farming, keeping mainly cattle and pigs which act as reservoirs for T.b. rhodesiense.
Outbreaks of Human African Trypanosomiasis due to T.b. rhodesiense occurred in Buteba (1990-91), Kisoko (1992-93) and Osukuru (2001-02) foci in Tororo district. Outbreaks were monitored through the number and places of origin of patients admitted at the LIRI Hospital--a sleeping sickness treatment centre in Tororo district. In turn, an advance medical team went ahead to create awareness among affected communities. The disease signs and symptoms, mode of transmission, and importance of cattle and pigs as reservoirs for T.b. rhodesiense were highlighted. At the end of each community education session people in the affected villages were asked to bring their cattle and pigs to designated areas for mass-treatment and insecticide-spraying by the veterinary team on programmed dates. The cluster of villages at different places that constituted the sleeping sickness foci were targeted during implementation of control interventions.
Control interventions were conducted in Kayoro Parish, Buteba Subcounty in March 1991, Petta Parish, Kisoko Subcounty in March 1993, and in Osukuru, Nyalakot and Kayoro Parishes, Osukuru Subcounty in April 2001. During the implementation of the control interventions, all cattle and pigs presented were treated with diminazene aceturate (Berenil[R], Hoechst GmBH, Germany) at a dosage rate of 7 mg/kg body weight. In addition, animal reservoirs were sprayed with deltamethrin pour-on (Spoton[R], Coopers, Harare, Zimbabwe) on the backline at a dosage rate of 1ml/10 kg body weight. For each village, the number of animals treated was recorded.
Following control interventions, sleeping sickness patients reporting to LIRI Hospital from Buteba, Kisoko and Osukuru foci were monitored through patient records from the time of the outbreaks in 1991 to 2008. As shown in Fig. 1, from January 1990 to March 1991, 59 patients presented for treatment from Buteba focus. During the proceeding outbreaks, 18 patients presented from Kisoko focus from May 1992 to February 1993 (Fig. 2) and 69 patients presented from Osukuru focus from January 2001 to January 2002 (Fig. 3).
The number of tsetse hosts and animal reservoirs (cattle and pigs) treated and sprayed during the outbreaks in Buteba, Kisoko and Osukuru foci are shown in Table 1. By January 2008, 6-17 years since the last outbreaks, no resurgence of sleeping sickness outbreak was observed in these foci.
Although cattle and pigs are the most important domestic animal reservoirs in south-east Uganda10, 13, 15, 17, 18, earlier interventions mainly targeted cattle as was the case in Buteba focus. This was mainly because cattle were the dominant livestock type in the area. Blood meal studies have shown that the number of times tsetse feeds on cattle is proportional to the number of cattle in the domestic herds (15). During intervening years, however, as more evidence unfolded, interventions targeted both cattle and pigs as was the case in Kisoko and Osukuru foci. Blood meal analysis has consistently shown that cattle, pigs and monitor lizards are the most preferred hosts for G. fuscipes fuscipes in south-east Uganda (15). Inclusion of pigs in mass treatment and insecticide spraying is of epidemiological significance given that communities in disease foci keep pigs within homesteads where G. fuscipes fuscipes is reported to be predomestic (19). Current thinking is that a whole range of domestic reservoirs, including cattle, pigs, sheeps and goats needs to be treated. Previous omission of pigs, sheeps and goats during treatment is reported to be partly responsible for the continued persistence of sleeping sickness in south-east Uganda (20). Upon realization of the importance of livestock reservoirs in propagation of cases of T.b. rhodesiense sleeping sickness in Uganda, Waiswa and Kabasa (21), embarked on a programme to treat 200,000 cattle with diminazene aceturate and spray them with deltametrin in the Districts of Soroti, Kaberamaido, Dokolo, Lira, Amolatar and Apac. This programme is reported to have decreased the prevalence of T. brucei s.l. in cattle by 70% within one year of implementation (21).
Combination of chemotherapy and application of insecticide pour-on on cattle is proven to exert rapid suppression of trypanosomiasis and tsetse population (22, 23). However, mass-treatment of livestock with isometamidium chloride coupled with limited vector control in some foci in Soroti of Uganda did not yield the desirable impact on the prevalence of T.b. rhodesiense in cattle (6). Because to be effective in the prevention of parasite transmission from livestock to people, mass-treatment and insecticide-spraying have to cover enough livestock (over 95%). In the present case study, the treatment and spraying campaign targeted over 95% of the cattle and pigs in the entire cluster of villages within the sleeping sickness focus. For logistic reasons, an approach involving gathering of cattle in designated communal areas coupled with "house-to-house visits" in search for pigs yielded excellent animal reservoir coverage. Combination of mass-treatment and vector control is likely to minimize occurrence and spread of drug resistant parasites. Economic evidence suggests that financial benefits of treating the animal reservoirs for T.b. rhodesiense sleeping sickness would be more than cover the costs of treatment (24). Treatment of animal reservoirs is beneficial to animal health and productivity. Lowering the incidence of sleeping sickness by treating animal reservoirs reduces the cost of treating human patients (24). In addition, it reduces the incidence of drug failure and toxicity associated with most especially melarsoprol--a drug for treatment of late stage cases (25,26).
In principle, livestocks for sale in sleeping sickness endemic areas in south-east Uganda are required to be treated before sale as a matter of Government policy (27), however, the policy has proved difficult to implement at a local level due to decentralization of public services (6). Different aspects of control, i.e. tsetse, human and animal trypanosomiasis being handled by different government departments in most sleeping sickness endemic countries is another bottleneck. Successful implementation of mass-treatment and insecticide-spraying of animal reservoirs demands for inter-sectoral cooperation among veterinary, agriculture and health services at all levels (25,26).
In conclusion, application of mass-treatment and insecticide-spraying of animal reservoirs in disease foci as an emergency control intervention for T.b. rhodesiense sleeping sickness outbreaks by governments is recommended. There is need for further studies on the integration of land-use practices that eliminate tsetse habitats with application of mass-treatment and spraying of animal reservoirs in rhodesiense sleeping sickness foci.
Key words Animal reservoirs; insecticide-spraying; mass chemotherapy; Trypanosoma brucei rhodesiense; tsetse control
We thank Betty Nyamaizi of LIRI Hospital for keeping track of the patients records. Control interventions received financial support from the European Union and Uganda Government for which we are grateful. This paper is published with the permission of the Director, National Livestock Resources Research Institute, Tororo, Uganda.
(1.) Cook JH. Notes on cases of 'sleeping sickness' occurring in the Uganda Protectorate. J Trop Med 1901; 4: 236-9.
(2.) MacKichan IW. Rhodesian sleeping sickness in eastern Uganda. Trans R Soc Trop Med Hyg 1944; 38: 49-60.
(3.) Abaru DE. Sleeping in Busoga, Uganda, 1976-1983. Trop Med Parasitol 1985; 36: 72-6.
(4.) Picozzi K, Fevre EM, Odiit M, Carrington M, Eisler MC, Maudlin I, Welburn SC. Sleeping sickness in Uganda: a thin line between two fatal diseases. BMJ 2005; 331: 1238-41.
(5.) Welburn SC, Picozzi K, Fevre EM, Coleman PG, Odiit M, Carrington M, Maudlin I . Identification of human-infective trypanosomes in animal reservoir of sleeping sickness in Uganda by means of serum-resistance-associated (SRA) gene. Lancet 2001; 358: 2017-9.
(6.) Fevre EM, Picozzi K, Fyfe J, Waiswa C, Odiit M, Coleman PG, Welburn SC. A burgeoning epidemic of sleeping sickness in Uganda. Lancet 2005; 366: 745-7.
(7.) Simarro PP, Cecchi, G, Paone, M, Franco JR, Diarra A, Ruiz JA, Fevre EM, Courtin F, Mattioli RC, Jannin JG. The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases. Int J Health Geogr 2010; 9: 57. http://www.ij-healthgeographics.com/cpntent/9/57.
(8.) Control and surveillance of African trypanosomiasis. Report of a WHO Expert Committee on Sleeping Sickness. WHO Tech Rep Ser 881; 1998.
(9.) Fevre EM, Coleman PG, Odiit M, Magona JW, Welburn SC, Woolhouse MEJ. The origins of a new Trypanosoma brucei rhodesiense sleeping sickness outbreak in eastern Uganda. Lancet 2001; 358(9282): 625-8.
(10.) Waiswa C, Olaho-Mukani W, Katunguka-Rwakishaya E. Domestic animals as reservoirs for sleeping sickness in three endemic foci in south-eastern Uganda. Ann Trop Med Parasitol 2003; 97(2): 149-55.
(11.) Odiit M. Approaches to trypanosomiasis control in Uganda. Newsletter on Integrated Control of Pathogenic Trypanosomes and their Vectors 2003; 8: 23.
(12.) Okuna NM, Mayende JSP. The incidence of trypanosomiasis in domestic animals and their role in the sleeping sickness epidemic in Busoga. In: Proceedings of the 17th Meeting of the International Scientific Council for Trypanosomiasis Research and Control (ISCTRC); Arusha, Tanzania; 1981 Oct 19-24; Organization of African Unity/Scientific, Technical and Research Commission; Nairobi, Kenya; 1983: 163-7.
(13.) Magona JW, Kakaire DW, Mayende JSP. Prevalence and distribution of animal trypanosomiasis on Buvuma Islands in Lake Victoria, Uganda: Short communication. Trop Anim Health Prod 1999; 31: 83-7.
(14.) Magona JW, Walubengo J, Odiit M, Okedi LA, Abila P, Katabazi BK, Gidudu AM, Olaho-Mukani W. Implications of the re-invasion of south-east Uganda by Glossina pallidipes on the epidemiology of bovine trypanosomosis. Vet Parasitol 2005; 128 (1-2): 1-9.
(15.) Waiswa C, Picozzi K, Katunguka-Rwakishaya E, Olaho-Mukani W, Musoke RA, Welburn SC. Glossina fuscipes fuscipes in the trypanosomiasis endemic areas of south-eastern Uganda: Apparent density, trypanosome infection rates and host feeding preferences. Acta Tropica 2006; 99: 23-9.
(16.) Magona JW, Walubengo J, Olaho-Mukani W. Knowledge and attitudes of cattle owners regarding trypanosomosis control in tsetse-infested areas of Uganda. J S Afr Vet Assoc 2004a; 75(4): 173-6.
(17.) Okuna, NM, Mayende JSP, Guloba A. Trypanosoma brucei infection in domestic pigs in a sleeping sickness epidemic area of Uganda. Acta Tropica 1986; 43: 183-4.
(18.) Lancien J, Muguwa J, Lannes C, Bouvier JB. Tsetse and Human trypanosomosis challenge in south-eastern Uganda. Insect Sci Appl 1990; 11: 411-6.
(19.) Okoth JO. Peridomestic breeding sites of Glossina fuscipes fuscipes Newst in Busoga, in Uganda and epidemiological implications for trypanosomiasis. Acta Tropica 1986; 43: 283-6.
(20.) Waiswa C. Porcine trypanosomiasis in south-eastern Uganda: Prevalence and assessment of therapeutic effectiveness. BJVM 2005; 8(1): 59-68.
(21.) Waiswa C, Kabasa JD. Experiences with an in-training community service model in the control of zoonotic sleeping sickness in Uganda. J Vet Med Educ 2010; 27(3): 276-81.
(22.) Magona JW, Mayende, JSP, Okiria R, Okuna NM. Protective efficacy of isometamidium chloride and diminazene aceturate against natural Trypanosoma brucei, Trypanosoma congolense and Trypanosoma vivax infections in cattle under a suppressed tsetse population in Uganda. Onderstepoort J Vet Res 2004b; 71(3): 231-7.
(23.) Magona JW, Okuna NM, Katabazi B, Okoth JO, Omollo P, Mayende JSP, Drabile DC. Control of tsetse and animal trypanosomosis by combination of pour-on, trapping and chemotherapy along the Uganda-Kenya border. Rev Elev Med Vet Pays Trop 1998; 51(4): 311-5.
(24.) Shaw APM. Economics of African trypanosomiasis. In: Maudlin I, Holmes PH, Miles MA eds. The trypanosomiasis. Oxford: CABI 2004; p. 369-402.
(25.) Welburn SC, Odiit M. Recent developments in human African trypanosomiasis.Curr Opin Infect Dis 2002; 15: 477-84.
(26.) Kioy D, Mattock N. Control of sleeping sickness-time to integrate approaches. Lancet 2005; 366: 695-6.
(27.) Olaho-Mukani W. Uganda revises cattle treatment to protect humans from sleeping sickness. Lancet 2002; 359: 239.
J.W. Magona & J. Walubengo
National Livestock Resources Research Institute, Tororo, Uganda
Correspondence to: Dr Joseph Magona, National Livestock Resources Research Institute, P.O. Box 96, Tororo, Uganda. E-mail: firstname.lastname@example.org
Received: 31 January 2011 Accepted in revised form: 14 April 2011
Table 1. Number of cattle and pigs treated and sprayed in respective foci and the duration since the last outbreak Sleeping sickness foci Buteba Kisoko Osukuru No. of cattle treated and sprayed 1791 937 1771 No. of pigs treated and sprayed -- 224 18 Duration since outbreak to 2008 (yr) 17 15 6 Fig. 1: Distribution of T.b. rhodesiense sleeping sickness patients from Buteba focus in Tororo district, Uganda during the outbreak from 1990 to 1991. Time (months) Jan '90 1 Feb '90 2 Mar '90 4 Apr '90 1 May '90 Jun '90 6 Jul '90 7 Aug '90 18 Sep '90 6 Oct '90 13 Dec '90 Jan '91 Feb '91 1 Mar '91 Note: Table made from bar graph. Fig. 2: Distribution of T.b. rhodesiense sleeping sickness patients from Kisoko focus in Tororo district, Uganda during the outbreak from 1992 to 1993. No. of patients Time (months) May '92 1 Jun '92 Jul '92 4 Aug '92 5 Sep '92 2 Oct '92 1 Nov '92 1 Dec '92 3 Jan '93 1 Feb '93 Mar '93 Note: Table made from bar graph. Fig. 3: Distribution of T.b. rhodesiense sleeping sickness patients from Osukuru focus in Tororo district, Uganda during the outbreak from 2001 to 2002. No. of patients Time (months) Jan '01 3 Feb '01 6 Mar '01 16 Apr '01 8 May '01 8 Jun '01 8 Jul '01 2 Aug '01 4 Sep '01 3 Oct '01 3 Nov '01 5 Dec '91 3 Jan '91 Note: Table made from bar graph.
|Printer friendly Cite/link Email Feedback|
|Author:||Magona, J.W.; Walubengo, J.|
|Publication:||Journal of Vector Borne Diseases|
|Date:||Jun 1, 2011|
|Previous Article:||A study on coverage, compliance and awareness about mass drug administration for elimination of lymphatic filariasis in a district of West Bengal,...|
|Next Article:||Insecticide susceptibility profile of the principal malaria vector, Anopheles gambiae s.l. (Diptera: Culicidae), in north-central Nigeria.|